Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2022-08-05 5:23 pm Purchase | 13G | Kiora Pharmaceuticals, Inc. KPRX | Lind Global Fund II LP | 3,666,750 9.9% | 3,232,439![]() (+744.27%) | View |
2022-08-01 06:06 am Purchase | 13G | Kiora Pharmaceuticals, Inc. KPRX | INTRACOASTAL CAPITAL, LLC | 3,467,774 9.99% | 3,467,774![]() (New Position) | View |
2022-07-28 5:09 pm Purchase | 13G | Kiora Pharmaceuticals, Inc. KPRX | Lincoln Park Capital Fund, LLC | 3,280,476 9.99% | 3,280,476![]() (New Position) | View |
2022-02-14 6:19 pm Purchase | 13G | Kiora Pharmaceuticals, Inc. KPRX | ARMISTICE CAPITAL, LLC | 2,131,101 14.4% | 2,131,101![]() (New Position) | View |
2022-02-11 5:07 pm Purchase | 13G | Kiora Pharmaceuticals, Inc. KPRX | Lind Global Fund II LP | 434,311 3.3% | 434,311![]() (New Position) | View |
2022-01-27 4:48 pm Purchase | 13G | Kiora Pharmaceuticals, Inc. KPRX | BIGGER CAPITAL FUND L P | 434,311 3.3% | 434,311![]() (New Position) | View |
2022-01-24 10:33 am Purchase | 13G | Kiora Pharmaceuticals, Inc. KPRX | Empery Asset Management, LP | 534,311 4.05% | 534,311![]() (New Position) | View |
2021-08-20 4:45 pm Purchase | 13G | Kiora Pharmaceuticals, Inc. KPRX | Lind Global Fund II LP | 1,302,933 9.9% | 1,302,933![]() (New Position) | View |
2021-08-20 4:40 pm Purchase | 13G | Kiora Pharmaceuticals, Inc. KPRX | Empery Asset Management, LP | 868,622 6.88% | 868,622![]() (New Position) | View |
2021-08-19 4:30 pm Purchase | 13G | Kiora Pharmaceuticals, Inc. KPRX | BIGGER CAPITAL FUND L P | 797,213 6.3% | 797,213![]() (New Position) | View |
2021-08-18 4:17 pm Purchase | 13G | Kiora Pharmaceuticals, Inc. KPRX | INTRACOASTAL CAPITAL, LLC | 460,978 3.5% | 460,978![]() (New Position) | View |
2021-08-17 4:45 pm Purchase | 13G | Kiora Pharmaceuticals, Inc. KPRX | Lind Global Macro Fund LP | 1,302,933 9.9% | 1,302,933![]() (New Position) | View |
2021-08-13 4:01 pm Unchanged | 13G | Kiora Pharmaceuticals, Inc. KPRX | ARMISTICE CAPITAL, LLC | 2,916,101 19.8% | 0 (Unchanged) | View |
2021-08-03 5:04 pm Sale | 13D | Kiora Pharmaceuticals, Inc. KPRX | ARMISTICE CAPITAL, LLC | 2,916,101 28.9% | -1,883,000![]() (-39.24%) | View |
2021-02-09 2:53 pm Sale | 13G | Kiora Pharmaceuticals, Inc. KPRX | Hudson Bay Capital Management LP | 0 0% | -328,192![]() (Position Closed) | View |
2021-01-12 5:08 pm Purchase | 13D | Kiora Pharmaceuticals, Inc. KPRX | ARMISTICE CAPITAL, LLC | 4,799,101 56.2% | 1,554,101![]() (+47.89%) | View |
2020-02-05 2:21 pm Purchase | 13G | Kiora Pharmaceuticals, Inc. KPRX | Hudson Bay Capital Management LP | 328,192 8.11% | 328,192![]() (New Position) | View |
2020-01-27 4:57 pm Sale | 13G | Kiora Pharmaceuticals, Inc. KPRX | Lau Jonathan | 15,798 0.43% | -3,793,582![]() (-99.59%) | View |
2020-01-15 4:46 pm Unchanged | 13D | Kiora Pharmaceuticals, Inc. KPRX | ARMISTICE CAPITAL, LLC | 3,245,000 54.1% | 0 (Unchanged) | View |
2020-01-10 4:07 pm Unchanged | 13D | Kiora Pharmaceuticals, Inc. KPRX | ARMISTICE CAPITAL, LLC | 3,245,000 54.1% | 0 (Unchanged) | View |